CD4 and COVID-19: This notion has been demonstrated by Henry et al. in their meta-analysis: the number of lymphocytes, particularly CD4 lymphocytes, can serve as a biological predictor of severity and mortality; in the case of COVID-19, they also reported the hypothesis that survival may depend on the ability to restore lymphocytes that are killed by the virus [22].